Skip to content
The Nexus
DossierENTITY

obesity drug market

Coverage of obesity drug market in the Nexus archive.

Earliest in view: Apr 14 · 15:02 UTCMost recent: Apr 14 · 15:02 UTC
Co-mentioned in this coverage
Novo Nordiskorganization1OpenAIorganization1Ozempictopic1Wegovytopic1
Recent coverage
  • BUSINESSApr 14 · 15:02 UTCTHE HILL
    Novo Nordisk partners with OpenAI in weight loss drug race

    Novo Nordisk, a Danish pharmaceutical company known for its weight-loss drugs Ozempic and Wegovy, has partnered with OpenAI to leverage AI technology in its operations. The collaboration aims to analyze complex datasets and identify promising drug candidates to stay competitive in the expanding obesity drug market.